"And also, make sure to ask about clinical trials. All of our treatments that we have today came through clinical trials, and by asking for a clinical trial, by potentially enrolling on a clinical trial, I tell people this is giving you the opportunity to have access to a medication that could be the next thing that revolutionizes how we treat the disease, and getting it sooner.”
Berger emphasized that for patients, enrolling in a clinical trial is not “being a guinea pig.”
“All of these medications have gone through rigorous processes where they're looked at, and sometimes they're looked at in other diseases and then brought to breast cancer or another disease,” she said. “Sometimes there are trials where it is first in human and for some people those may not be the right option, but some of these trials really are incredible opportunities.
“And so, ask the questions, hear about something before saying no, to better understand if this does sound like it's the right option for you. … No matter what you've heard about clinical trials, no matter what you think, ask the questions. It's always better to have more information than less. Knowledge is power. And so, the more you can learn, the more you can know about what options are available to you, the better.”
This article was supported by Gilead Sciences, Inc., but editorially independently created by the CURE team."
https://www.curetoday.com/view/breaking-down-...treatments